Popular

Potential Impact of Aryl Hydrocarbon Activation on Pigment
Practical DermatologyPotential Impact of Aryl Hydrocarbon Activation on Pigment

Tapinarof’s Place in Inflammatory Disease Treatment
Practical DermatologyTapinarof’s Place in Inflammatory Disease Treatment

Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Practical DermatologyMechanism of Action for Aryl Hydrocarbon Receptor Agonists

Various Benefits of Aryl Hydrocarbon Receptor Agonists
Practical DermatologyVarious Benefits of Aryl Hydrocarbon Receptor Agonists

A Multidisciplinary Approach to Treating Itch
Dermatology Hub: Neuroimmune NetworkA Multidisciplinary Approach to Treating Itch

The Treatment Planning Process for Atopic Dermatitis
Dermatology Hub: Neuroimmune NetworkThe Treatment Planning Process for Atopic Dermatitis
Programs

Managing Patient Expectations with Topical Therapies
Practical DermatologyManaging Patient Expectations with Topical Therapies

Various Benefits of Aryl Hydrocarbon Receptor Agonists
Practical DermatologyVarious Benefits of Aryl Hydrocarbon Receptor Agonists

The Treatment Planning Process for Atopic Dermatitis
Dermatology Hub: Neuroimmune NetworkThe Treatment Planning Process for Atopic Dermatitis

ADORING Trials Show Broad Efficacy, Early Itch Relief
Practical DermatologyADORING Trials Show Broad Efficacy, Early Itch Relief

Why Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Practical DermatologyWhy Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Clinical Practice

Key Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis
CardiologyKey Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis

Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care

Treatment Considerations in Ulcerative Colitis: Shared Decision-Making
Medical Industry FeatureTreatment Considerations in Ulcerative Colitis: Shared Decision-Making

Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
CME/CETranslating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum

INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice

The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiersThe New Era of Targeted Therapy for Myasthenia Gravis
Doctors Lounge

The Missing Link in Clinical AI: Unlocking Institutional Knowledge
The ConvergenceThe Missing Link in Clinical AI: Unlocking Institutional Knowledge

Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI

Humanoids in Healthcare: Extending the Reach of Surgical Expertise
The ConvergenceHumanoids in Healthcare: Extending the Reach of Surgical Expertise

Why Disparities in Asthma Care Persist and How They Affect Children
Clinician's RoundtableWhy Disparities in Asthma Care Persist and How They Affect Children
CME

Translating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD
CME/CETranslating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD

Unmasking HCM in Patients With Preserved EF: Diagnostic Clarity, Evolving Evidence, and Emerging Therapeutic Strategies
CME/CE Broadcast ReplayUnmasking HCM in Patients With Preserved EF: Diagnostic Clarity, Evolving Evidence, and Emerging Therapeutic Strategies

Individualizing Management Strategies for PSVT: Incorporating Patient Preference
MinuteCE®Individualizing Management Strategies for PSVT: Incorporating Patient Preference

SOHO 2026 Debrief: Translating the Latest CLL Data Into Community Practice Decisions
CME/CESOHO 2026 Debrief: Translating the Latest CLL Data Into Community Practice Decisions

Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
Industry Feature

Single-Port Robotics Improves Outcomes for Thoracic Surgery
Medical Industry FeatureSingle-Port Robotics Improves Outcomes for Thoracic Surgery

All-Oral Regimen for AML Provides New Treatment Pathway
Medical Industry FeatureAll-Oral Regimen for AML Provides New Treatment Pathway

Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment

Quick Takes in ATTR-CM: Diagnosis Barriers
Medical Industry FeatureQuick Takes in ATTR-CM: Diagnosis Barriers

A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist

Guiding Long-Term Care in Friedreich Ataxia
Medical Industry FeatureGuiding Long-Term Care in Friedreich Ataxia


















































































































